The main purpose of this NIST is to propose nanobiotechnological innovations to solve public health problems, by improving the control of infectious and chronic diseases with a theranostics vision. For this, experts of various fields of knowledge will develop new nanobiotechnological platforms based on combinatorial molecules integrated with applied technologies of microfluidics, biophotonics, nanomaterials and electrochemistry for improved diagnosis and treatment of various diseases.